The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: Results of a clinical/correlative prospective phase II clinical trial

A. P. Algazi, E. Cha, S. M. Ortiz-Urda, T. McCalmont, B. C. Bastian, J. Hwang, M. H. Pampaloni, S. Behr, K. Chong, B. Cortez, A. Quiroz, F. Coakley, S. Liu, A. I. Daud

Research output: Contribution to journal › Article › peer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: Results of a clinical/correlative prospective phase II clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences